Beta-Lactam Derivatives with Double Triazole Functionality
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing beta-lactam derivatives face challenges in producing stable and functionalized compounds with enhanced antibiotic activity, particularly against resistant bacteria and fungi, due to limitations in the synthesis of Cephalosporanic nucleus derivatives and the instability of ester groups.
Innovation Solution
A multi-step synthetic strategy involving the transformation of beta-lactam nuclei into ester and amide derivatives with azide or propargyl groups, allowing for the formation of branched structures with double triazole functionality, which enhances stability and functionalization, including copper-catalyzed cycloaddition reactions.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If ester derivatives of beta-lactam nuclei are synthesized, then molecular diversity is increased, but stability of the compounds deteriorates
Solution Approach 1:
The patent segments the beta-lactam derivative library into two distinct stability categories: ester derivatives (Formula 1) providing high molecular diversity and amide derivatives (Formula 2) providing enhanced stability. This segmentation allows researchers to select appropriate derivatives based on whether diversity or stability is the priority for their specific application.
Solution Approach 2:
The patent changes the chemical parameter at the R1 position from ester group (-COOR) in Formula 1 to amide group (-CONH2, -CONHR, or -CONR2) in Formula 2. This parameter change fundamentally alters the stability profile while maintaining the core beta-lactam structure and pharmacological activity.
2Device complexity
If simple beta-lactam derivatives are synthesized, then synthesis complexity is reduced, but antibiotic activity against resistant bacteria deteriorates
Solution Approach 1:
The patent segments derivatives into simple esters (Formula 1) for easier synthesis and complex amides (Formula 2) for enhanced activity against resistant bacteria. The segmented approach allows selection based on whether synthesis simplicity or antibiotic efficacy is the primary concern.
Solution Approach 2:
The patent creates composite molecular structures by combining the beta-lactam core with various substituent groups (R1-R6) including amide groups, azide groups, and propargyl groups. These composite structures enhance antibiotic activity against resistant bacteria while maintaining manageable synthesis complexity through systematic substitution patterns.
3Manufacturing precision
If single-functionalized beta-lactam derivatives are synthesized, then manufacturing precision is improved, but pharmacological versatility deteriorates
Solution Approach 1:
The patent segments functionalization into single-substituent esters (Formula 1) for precise synthesis and multi-substituent amides (Formula 2) with multiple azide or propargyl groups for enhanced pharmacological versatility. The segmentation enables selection based on whether synthesis precision or pharmacological adaptability is prioritized.
Solution Approach 2:
The patent creates universal beta-lactam derivatives by introducing multiple functional groups (azide, propargyl, amide) at different positions (R1-R6) that can participate in various biochemical interactions. The multi-functionalized amide derivatives (Formula 2) serve multiple pharmacological functions including enhanced antibiotic activity, antifungal activity, and potential for further chemical modification.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables the creation of new beta-lactam derivatives with improved stability, enhanced antibiotic activity, and increased resistance to bacterial defense systems, overcoming the limitations of previous methods by producing compounds with double triazole functionality and complex structures.
Implementation Method 1
The present invention relates to the cycloaddition reaction catalyzed by copper to give new beta-lactam derivatives starting from azide esters and amides and from dipropargyl tertiary amides to obtain new derivatives of β-lactam nuclei containing differently functionalized triazoles
Data Source
Figure 1~3
Figure 4
Figure 5~6
AI summary
The present invention relates to a process for the synthesis of derivatives of β-lactam compounds and a process for the synthesis of triazole derivatives of β-lactam compounds starting from said precursors, the relative precursors and derivatives and their use as a medicament.